CJ Cheiljedang (097950) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
23 Jun, 2026Executive summary
Overseas food sales grew 8% year-over-year, led by a turnaround in China, growth in Japan, and expansion in Europe and Australia, while Korea's packaged food market rapidly shifted online with digital sales up 33% and now over 20% of total.
Bio business improved bulky amino acid performance due to global protectionism, anti-dumping tariffs in Europe, and competitor exits in the Americas.
Feed & Care segment achieved a profit turnaround, with operating profit up KRW 50.5bn YoY and 52% QoQ, driven by strong hog prices in Vietnam and business restructuring.
Financial highlights
Q1 2025 sales excluding logistics dropped 1.8% year-over-year to KRW 4.363 trillion; operating profit fell 7.8% to KRW 246.3 billion; net profit declined 73% to KRW 26.9 billion, impacted by higher corporate tax.
Including logistics, Q1 sales were KRW 7.2085 trillion (flat YoY); operating profit decreased 11.4% to KRW 333.2 billion; net profit was KRW 17.6 billion.
Food sales grew 3% YoY to KRW 2,925 billion, but operating profit dropped 30% to KRW 128.6 billion due to high raw material costs and lower gift set sales in Korea.
Bio sales declined 12% to KRW 895.4 billion; operating profit down 16% to KRW 82.6 billion.
Feed & Care sales fell 8% to KRW 542.5 billion, but operating profit rose by over KRW 50 billion YoY to KRW 35.2 billion.
Logistics sales increased 2% to KRW 2,993 billion; operating profit dropped 22% to KRW 85.4 billion.
Outlook and guidance
Q2 2025 sales growth projected in the low to mid single digits, with an operating profit margin of about 6%.
Food Global expects normalization of U.S. dessert production, sustained growth in Japan/China, and continued expansion in Europe/Australia.
Food Korea anticipates growth via online transition and new products despite raw material cost pressures.
Bio expects profit improvement as favorable market conditions for bulky amino acids take effect.
Feed & Care expects solid profit generation despite macroeconomic headwinds in Indonesia.
Latest events from CJ Cheiljedang
- Operating profit up 39% YoY, but net profit negative on asset impairments and FX losses.097950
Q4 202423 Jun 2026 - Overseas and bio growth offset weak domestic demand, boosting net profit despite lower operating profit.097950
Q2 202523 Jun 2026 - Q2 OP up 14% YoY, net profit up 59.5%, with strong bio and overseas food growth.097950
Q2 202423 Jun 2026 - Q3 OP rose as global, bio, and logistics gains offset Korea declines; YTD profit up sharply.097950
Q3 202423 Jun 2026 - Q1 2026 revenue up 6%, net income doubled, but operating profit fell on BIO margin pressure.097950
Q1 202622 Jun 2026 - Overseas food growth offset by Bio weakness, leading to net losses and a cautious 2026 outlook.097950
Q4 202515 May 2026 - Bio and feed & care weakness drove profit declines, but food and logistics grew.097950
Q3 202517 Dec 2025